Accordingly, ING3 loss of expression has been reported in a number of human cancers, such as gynecological malignancies [66], where its high expression at the nucleus of cancer cells is reported to be associated with good prognosis in breast cancer patients and downregulation of its mRNA correlates with poor prognosis in head and neck malignancies [67, 68]. This evidence concerns the gene ING3 and breast cancer.